Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. - Wikidata - awgldk - TriplyDB

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.

http://www.wikidata.org/entity/Q44104837

about

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey Systemic antibiotic therapy for chronic osteomyelitis in adults Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection.Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates Evaluation of the automated Vitek 2 system for detection of various mechanisms of macrolide and lincosamide resistance in Staphylococcus aureus.Adherence to CLSI recommendations for testing of Staphylococcus aureus isolates in Louisiana hospitals: report of a clinical failure and results of a questionnaire study.Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates.MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006.Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002.Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients Community-associated methicillin-resistant Staphylococcus aureus: a review.Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000-2013.The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections.Community-acquired methicillin-resistant staphylococcus aureus: an emerging problem in the athletic population.Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Community-associated meticillin-resistant Staphylococcus aureus Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes.Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions.Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.The prevalence of inducible clindamycin resistance among staphylococci in a tertiary care hospital - a study from the garhwal hills of uttarakhand, India Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention.Modes and modulations of antibiotic resistance gene expression.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Update on clindamycin in the management of bacterial, fungal and protozoal infections.Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance.Prevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean tertiary care hospital.Treatment and recurrence management of staphylococcal infections: community-acquired MRSA.Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing.Community-associated Staphylococcus aureus infections in children.Invasive community-associated MRSA infections: epidemiology and antimicrobial management.

P2860

Q24614464-29891BB4-939B-45A4-9821-48D8E9642D68 Q24643277-E8CC50A4-A7C6-47A4-AC69-0942E7C0B1AA Q28235095-04DA96D5-C428-4EC2-B43C-B7D922FA7059 Q28714211-2E079945-5223-4D09-98AB-8AB6483C844B Q33264579-24CB45D6-A043-453D-A6CC-AE0531637F89 Q33827292-274F9541-E59B-4333-B892-0E4E3BF71948 Q33836641-EA715C61-C523-45B1-80A1-2F9A510BB491 Q34157657-61EA7B0C-1894-44EC-B138-DB1775081DB1 Q34719746-D3297859-A019-4722-80CF-BE463A47BA28 Q35036119-BAE1633E-30F5-46E1-B7BF-5F06EA6AC70A Q35139881-04899159-E189-4194-AE71-27F1E362535C Q35805583-97F6442B-D7A1-4DE9-833C-8BBB8870BF7A Q35845890-6CDF3C26-E017-4FBE-8CEB-187111C240DA Q35873382-05603C80-0255-4A25-B6C8-F24A5210CDC8 Q35913984-BE2F21EF-C42F-4EBE-83C4-D8B03C51B313 Q36009370-8F9FD0FE-7466-4757-AF7D-DEF89766CC92 Q36070903-DE37280E-C801-49A4-AB59-467D88C1B292 Q36071256-E885A083-E7D0-4497-BE49-A8343976A5B6 Q36212072-E77E73C2-DD95-4540-A13D-6445D48F2552 Q36242617-CEBE939E-E374-46EE-9F28-5FDF94D84E8C Q36325494-0B3ACB77-F543-44E1-820B-3680AA10EE78 Q36379346-8DFD975E-D28F-41E7-B818-AA0334882A70 Q36409465-D9216A1C-858D-4CD4-8CF2-38EA57D8BCBC Q36438720-4A4ED6A8-B370-4DDE-9355-D9E980E1B6B5 Q36452596-41030302-073C-4D55-A577-5F39A970DA72 Q36497964-7A2AA7EB-6958-4D22-80C3-20CAC03E98C1 Q36563779-6A7B237E-6617-4E77-86A7-7A8653340454 Q36622487-4A72CDAE-EB47-4BEF-92E7-7476E50294BB Q36703883-D97CB773-0750-454E-9B4B-DAD274E68C78 Q36708242-BC9BAB5B-1673-4E5C-A5A4-8825CCBDB6CF Q36718474-51AE0908-C2EF-44FA-AC0E-284395B4C9A5 Q36758570-697AB04C-5D6C-4DAB-A623-C2CB8A745BF5 Q36967293-59F41E39-63AB-49B6-B440-D69193926F79 Q36999966-2D72DF5E-8F4A-49D8-A37B-FCBB88C0D87E Q37146565-1C9E4F84-AAD4-4473-98E6-BBFFF5608F5C Q37205609-F757F208-0062-4D4D-816A-E2B1E41B935C Q37340558-9817A31B-E29D-4F44-B10A-224868F61201 Q37421099-46C65DB3-4F56-495B-8418-77CBD20198B8 Q37747396-C44AA710-88E8-45A1-B6C2-A493498DCB13 Q37800939-8EDF14FE-C97A-4D18-870F-3747849A7562

P2860

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.

http://www.wikidata.org/entity/Q44104837

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Clindamycin treatment of methi ...... aureus infections in children.

@en

Clindamycin treatment of methi ...... aureus infections in children.

@nl

type

label

Clindamycin treatment of methi ...... aureus infections in children.

@en

Clindamycin treatment of methi ...... aureus infections in children.

@nl

prefLabel

Clindamycin treatment of methi ...... aureus infections in children.

@en

Clindamycin treatment of methi ...... aureus infections in children.

@nl

P1433

Q44104837-204726A6-2F98-4BE8-815E-13592F79DA45

P1476

Q44104837-42BB27A6-7D84-406D-A3C7-86905EBC976D

P2093

Q44104837-0674E9DE-FF27-43A0-8630-6A5812F73373

Q44104837-599326E5-3874-4AFE-9049-5C32D7C01929

Q44104837-7BF25EB4-11C3-4EB8-9392-B05902C085BE

Q44104837-7D71A8D3-067C-4B40-A28E-889F44EB6BD8

Q44104837-B0A12704-6746-4601-9BE9-076B4EFB1822

Q44104837-BBFF1209-935E-4D98-A728-19F4D0AA5332

Q44104837-C9FCA850-ED16-432B-9FCC-E1A46E21EE38

P304

Q44104837-BB48BCBD-C0C8-43F1-A576-20FC3ED88202

P31

Q44104837-048B3ABE-F636-400B-9D95-1936BC2A31C2

P356

Q44104837-EC4423A2-BE62-45AF-94DA-DA66F19B643E

P433

Q44104837-F24D57D3-ECAE-4D74-8E6B-C727D74B193B

P478

Q44104837-87C42CEA-C087-4864-9570-C1E731F5A218

P577

Q44104837-4943AA43-3A13-4EC9-A55D-EDCBD683DDE1

P698

Q44104837-1A2D80C2-6D72-4031-A3E5-DB5475B3F32E

P921

Q44104837-D78CE64C-1AF8-4E7E-A448-D6395042FEDD

P356

00006454-200206000-00010

P1433

Pediatric Infectious Disease Journal

P1476

Clindamycin treatment of methi ...... aureus infections in children.

@en

P2093

Arthur L Frank

http://www.w3.org/2001/XMLSchema#string

John F Marcinak

http://www.w3.org/2001/XMLSchema#string

John P Quinn

http://www.w3.org/2001/XMLSchema#string

Joyce T Tjhio

http://www.w3.org/2001/XMLSchema#string

P Daisy Mangat

http://www.w3.org/2001/XMLSchema#string

Paul C Schreckenberger

http://www.w3.org/2001/XMLSchema#string

Swathi Kelkar

http://www.w3.org/2001/XMLSchema#string

P304

530-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00006454-200206000-00010

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12182377

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus